What Can Consumer Adverse Drug Reaction Reporting Add to Existing Health Professional-Based Systems?: Focus on the Developing World

Author： Fernandopulle R.B.M. Weerasuriya K.

Publisher： Adis International

ISSN： 0114-5916

Source： Drug Safety, Vol.26, Iss.4, 2003-01, pp. : 219-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Consumer Adverse Drug Reaction Reporting: A New Step in Pharmacovigilance?

By van Grootheest K.

Drug Safety, Vol. 26, Iss. 4, 2003-01 ,pp. : 211-217

Adis International

Access to resources Recommend Favorite

Intermediate organisations: a solution for `solidaristic' health systems?

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 262, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Does Pharmacogenomics Provide an Ethical Challenge to the Utilisation of Cost-Effectiveness Analysis by Public Health Systems?

By Adam La Caze

PharmacoEconomics, Vol. 23, Iss. 5, 2005-01 ,pp. : 445-447

Adis International

Access to resources Recommend Favorite

Consumer Reporting of Adverse Drug Reactions: A Retrospective Analysis of the Danish Adverse Drug Reaction Database from 2004 to 2006

By Aagaard Lise > >

Drug Safety, Vol. 32, Iss. 11, 2009-11 ,pp. : 1067-1074

Adis International

Access to resources Recommend Favorite

What Will Be the Role of Pharmacogenetics in Evaluating Drug Safety and Minimising Adverse Effects?

By Ozdemir V.

Drug Safety, Vol. 24, Iss. 2, 2001-01 ,pp. : 75-85

Adis International

Access to resources Recommend Favorite